Ferdinand Groenewald's most recent trade in Streamex Corp. was a trade of 60,000 Common Stock done . Disclosure was reported to the exchange on Nov. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biosig Tech Inc | Ferdinand Groenewald | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 60,000 | 295,000 (1%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Ferdinand Groenewald | Vice President of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2025 | 10,775 | 10,775 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Ferdinand Groenewald | Vice President of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2025 | 4,000 | 4,000 | - | - | Employee Stock Option (right to buy) | |
| Biosig Tech Inc | Ferdinand Groenewald | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 175,000 | 235,000 (0%) | 0% | 0 | Common Stock | |
| Biosig Tech Inc | Ferdinand Groenewald | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 35,000 | 60,000 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Ferdinand Groenewald | VP, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2025 | 3,000 | 3,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Ferdinand Groenewald | VP, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 1,500 | 1,500 | - | - | Employee Stock Option (right to buy) | |
| Sadot Grp Inc | Ferdinand Groenewald | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 25,000 | 25,000 | - | - | Stock Options | |
| Sadot Grp Inc | Ferdinand Groenewald | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 15 Feb 2022 | 19,285 | 0 | - | 0.6 | 11,185 | Common Stock |
| Sadot Grp Inc | Ferdinand Groenewald | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 2.87 per share. | 11 Feb 2021 | 19,285 | 19,285 | - | 2.9 | 55,348 | Common Stock |